Indian stocks: Visit www.stage2stocks.com →

Phreesia, Inc.

Stage 4 · Declining · week 4

As of Oct 22, 2026, Phreesia is in Stage 4, the downtrend phase, now in week 4 (since Sep 30, 2026). It closed at $12.72, 45.8% below its 52-week high and above its 200-day average, which is falling.

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. More about the company

$12.72
+3.75% today
$790M · Small cap
Market Neutral — Building

Pro read

Pro

Our read

Declining, below its long-term trend

Setup score

—

Momentum

Accelerating ⇈

Edge

—

Is PHR early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…
Stage Cycle Timeline2023-08-16 → 2026-10-22
S4 18w
S3 16w
S4 37w
2023-08-162026-10-22
S1S2S3S4Setup score (0–10, dashed line at 5)
S4 18w → S1 9w → S2 6w → S3 16w → S2 1w → S1 3w → S2 7w → S3 2w → S4 9w → S1 2w → S2 12w → S3 12w → S2 13w → S3 3w → S4 37w → S1 13w → S4 3w current
Total tracked: 165 weeks across 17 stage runs.

PHR among Health Information Services24th of 41 by relative strength

All 41 →
Stocks in Health Information Services ranked by relative strength, with stage and one-month change
#StockStageRS1M
1AMWLStage 2 · wk 2597+7.4%
2HNGEStage 2 · wk 2096+19.1%
3BTSGStage 3 · wk 894+9.1%
4NRCStage 3 · wk 493−0.1%
5SOPHStage 2 · wk 2491−12.7%
6HTFLStage 2 · wk 1087+17.0%
7HSTMStage 2 · wk 1777+20.3%
8OMCLStage 4 · wk 1070+12.5%
…24PHRStage 4 · wk 426+31.4%
vs 52W High
-45.8%
$8.06 lo$23.49 hi
45.8% below 52W high, deep Stage 4 damage
In Stage 4, distance from the 52-week high reflects an ongoing decline, not a discount.
Stage Maturity
Week 4
1w13w26w
Week 4, early Stage 4 decline
How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure. No length of decline marks a bottom on its own.
vs 200 DMA
15.0%
200 DMA: $11.06 · sloping down
In Stage 4, the stock is below its 200-day average, the hallmark of a downtrend. Stage analysis waits for that to reverse before buying.
Rel Volume
0.83x
vs 50-day avg
High volume on down days in Stage 4 confirms institutional selling. Low-volume bounces are typical. They lack real buyers and are easy to mistake for reversals.
Trend Health
↑ ⇈
Short-term trend rising strongly, and accelerating
Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.
1M
+31.4%
3M
+24.5%
6M
+43.7%
YTD
-22.0%
1Y
-45.0%
Scan Membership
Breakout Watch
Latest: 2025-06-26
11 appearances in last 60 days. First seen: 2020-06-23.
A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.
Recent Stage Timeline
2026-10-22S4
Wk 4 · Vol 0.83x
2026-10-21S4
Wk 4 · Vol 1.18x
2026-10-20S4
Wk 3 · Vol 1.38x
2026-10-19S4
Wk 3 · Vol 1.04x
2026-10-16S4
Wk 3 · Vol 0.89x
2026-10-15S4
Wk 3 · Vol 1.37x
2026-10-14S4
Wk 3 · Vol 0.75x
2026-10-13S4
Wk 2 · Vol 0.69x
2026-10-12S4
Wk 2 · Vol 0.72x
2026-10-09S4
Wk 2 · Vol 0.71x
2026-10-08S4
Wk 2 · Vol 0.92x
2026-10-07S4
Wk 2 · Vol 0.79x
Moving averages & range
50 DMA
$10.98
200 DMA
$11.06
52W High
$23.49
52W Low
$8.06
5D Low
$10.94
Resistance levels (recent highs)
20d High
$12.72
60d High
$12.72
120d High
$12.72
250d High
$23.48
Next resistance
+84.6%
to 250d High
P/E (TTM)
74.8
Forward 8.0
Earnings Growth (YoY)
+200.0%
Revenue +10.4%
ROE
+3.1%
Profit margin +2.1%
Dividend Yield
0.00%
P/B 2.1

Phreesia: quick answers

What stage is Phreesia in?

As of Oct 22, 2026, Phreesia (PHR) is in Stage 4, the downtrend phase. It entered Stage 4 on Sep 30, 2026 and is in week 4. What the four stages mean

Is Phreesia in an uptrend?

No. Phreesia is in a Stage 4 downtrend. It trades 15.0% above its 200-day average, which is falling.

How far is Phreesia from its 52-week high?

Phreesia closed at $12.72 on Oct 22, 2026, 45.8% below its 52-week high of $23.49. Its 52-week low is $8.06.

How has Phreesia performed over the past year?

As of Oct 22, 2026, Phreesia is down 45.0% over the past year and down 22.0% so far in 2026.

Which sector and industry is Phreesia in?

Phreesia is in the Health Information Services industry, part of the Health Care sector.

About this companyHealth Care· Health Information Services

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. It offers solutions including appointment optimization and referral management using AI-enabled workflows; and AI-based smart answering solution patient communications supported by voice and messaging solutions; integrated payment solutions embedded in intake and post-visit workflows, and financing solutions that enable healthcare organizations to accelerate cash collections while offering flexible payment options to patients; and digital intake and clinical data capture, patient engagement and activation tools, and measurement and analytics solutions. It also offers PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, which are on-site kiosks. The company serves a range of healthcare organizations including ambulatory practices, health systems, and hospitals, as well as life sciences companies, government entities, patient advocacy, public interest and not-for-profit and other organizations. Phreesia, Inc. was incorporated in 2005 and is based in Wilmington, Delaware.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.